Lotus Eye Hospital and Institute Limited has decided against proceeding with its voluntary delisting proposal from the National Stock Exchange of India Limited (NSE). The board of directors, in their meeting held on March 17, 2026, formally rejected the delisting proposal after considering current market conditions, liquidity factors, and the need to ensure continued investor convenience and flexibility.

Board Meeting Outcome

The healthcare company's board meeting commenced at 04:30 PM and concluded at 05:00 PM on March 17, 2026. The decision was communicated to both stock exchanges in compliance with Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015.

Rationale Behind Decision

The board cited several key factors in their decision-making process. Current market conditions played a significant role, along with liquidity considerations that could impact shareholder value. The company emphasized the importance of maintaining investor convenience and flexibility through continued dual exchange presence.

Continued Dual Exchange Presence

With this decision, Lotus Eye Hospital and Institute Limited will maintain its listing status on both major Indian stock exchanges. The company's equity shares will continue to be available for trading, providing investors with multiple avenues for transactions.

Corporate Operations

Lotus Eye Hospital and Institute Limited operates an extensive network of eye care facilities across South India. The company maintains locations in Coimbatore, Salem, Tirupur, Mettupalayam, Kochi, and Karur, positioning itself as a significant player in specialized eye care services across these regional markets. The company's registered office is located at 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, with CIN No. L85110TZ1997PLC007783.

Lotus eye hospital And Institute Limited has been penalized by both major Indian stock exchanges for regulatory non-compliance. The healthcare company disclosed that BSE Limited and National Stock Exchange of India Limited have each imposed fines of Rs 2,17,120, inclusive of GST, for violations under SEBI listing regulations.

Regulatory Violation Details

The penalty stems from non-compliance with Regulation 17(1A) of the SEBI (LODR) Regulations, 2015. The company received official communication regarding this action through email and letter dated February 27, 2026.

Remedial Actions Taken

Lotus Eye Hospital And Institute Limited has taken steps to address the compliance issue. The company rectified the non-compliance through shareholder approval obtained via postal ballot, with resolutions deemed to have been passed on January 17, 2026.

The company's board of directors acknowledged the non-compliance comments at their meeting held on February 11, 2026. Subsequently, the board's observations were communicated to both stock exchanges on February 12, 2026.

Financial Impact Assessment

According to the company's disclosure, the regulatory penalty will not have any material impact on its financial operations. The healthcare institution has also clarified that stock exchanges had previously levied fines up to the quarter ended September 30, 2025, which the company has duly paid.

Corporate Background

The present penalty specifically pertains to the quarter ended December 31, 2025. The company operates multiple healthcare facilities across Tamil Nadu and Kerala, with locations in Coimbatore, Salem, Tirupur, Mettupalayam, Kochi, and Karur, specializing in eye care services.